Table 1.
Low-Risk PE 46 patients |
Intermediate/ High-Risk PE 46 patients |
Intermediate- Risk PE 28 patients |
High-Risk PE 18 patients |
|||||
---|---|---|---|---|---|---|---|---|
Age (mean, SD†) | 62 | 15 | 62 | 16 | 61 | 18 | 64 | 12 |
n | % | n | % | n | % | n | % | |
Female | 20 | 43% | 20 | 43% | 13 | 46% | 7 | 39% |
Race: | ||||||||
White | 43 | 94% | 41 | 89% | 25 | 89% | 16 | 89% |
Black | 2 | 4% | 5 | 11% | 3 | 11% | 2 | 11% |
Other | 1 | 2% | 0 | 0% | 0 | 0% | 0 | 0% |
Ethnicity: | ||||||||
Non-Hispanic | 45 | 98% | 46 | 100% | 28 | 100% | 18 | 100% |
Hispanic | 1 | 2% | 0 | 0% | 0 | 0% | 0% | 0% |
Insurance: | ||||||||
Private | 27 | 59% | 32 | 70% | 20 | 72% | 12 | 67% |
Medicare | 17 | 37% | 11 | 24% | 6 | 21% | 5 | 28% |
Other | 2 | 4% | 3 | 6% | 2 | 7% | 1 | 5% |
Comorbidities: | ||||||||
Coronary Artery Disease‡ | 6 | 13% | 3 | 6% | 3 | 11% | 0 | 0% |
Congestive Heart Failure | 3 | 6% | 4 | 9% | 1 | 4% | 3 | 17% |
Lung Disease § | 10 | 22% | 10 | 22% | 6 | 21% | 4 | 22% |
Asthma | 5 | 11% | 4 | 9% | 2 | 7% | 2 | 11% |
COPD | 3 | 6% | 2 | 4% | 1 | 4% | 1 | 6% |
Other | 2 | 4% | 5 | 11% | 5 | 18% | 0 | 0% |
Malignancy¶ | 19 | 41% | 20 | 43% | 9 | 32% | 11 | 61% |
Active/Palliative | 8 | 17% | 8 | 17% | 1 | 4% | 7 | 39% |
Inactive | 10 | 22% | 12 | 26% | 8 | 29% | 4 | 22% |
Status Unknown | 1 | 2% | 0 | 0% | 0 | 0% | 0 | 0% |
Renal Insufficiency or Failure** | 1 | 2% | 2 | 4% | 2 | 7% | 0 | 0% |
Cerebrovascular Disease†† | 4 | 9% | 4 | 9% | 3 | 11% | 1 | 6% |
Table 1 Notes:
PE = Pulmonary Embolism;
SD = Standard Deviation;
COPD = Coronary Artery Disease includes any history of myocardial infarction, angina, coronary artery stenting or bypass surgery
Asthma, COPD and Other lung disease are not mutually exclusive.
Active malignancy includes any cancer that is being actively treated or palliated, and metastatic disease. Inactive cancer includes a prior history of cancer that is not actively being treated or palliated.
Renal insufficiency or failure includes renal insufficiency, renal failure and hemodialysis.
Cerebrovascular disease includes any history of ischemic or hemorrhagic stroke or transient ischemic attack.